SQSTM1 and liver disorder: The incorporation of KEAP1 into p62 bodies requires phosphorylation of p62 at serine 349 (Ikeda et al, 2023), implying that kinase activation or phosphatase inhibition in liver disorders may be linked to pathogenesis.